G01N 2333/918
Carboxylic ester hydrolases
Official title: Carboxylic ester hydrolases (3.1.1)
G01N2333/918 (Carboxylic ester hydrolases) appears on 216 US grants and 337 published applications in this corpus.
Search patents in G01N- Granted patents
- 216
- Published applications
- 337
- Assignees
- 219
- Inventors
- 735
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 1 |
| 2002 | 3 | 7 |
| 2003 | 4 | 8 |
| 2004 | 3 | 7 |
| 2005 | 4 | 12 |
| 2006 | 1 | 8 |
| 2007 | 5 | 18 |
| 2008 | 6 | 9 |
| 2009 | 8 | 16 |
| 2010 | 6 | 14 |
| 2011 | 12 | 15 |
| 2012 | 13 | 20 |
| 2013 | 8 | 20 |
| 2014 | 10 | 14 |
| 2015 | 9 | 24 |
| 2016 | 10 | 19 |
| 2017 | 9 | 17 |
| 2018 | 9 | 14 |
| 2019 | 11 | 9 |
| 2020 | 11 | 12 |
| 2021 | 6 | 9 |
| 2022 | 7 | 12 |
| 2023 | 3 | 10 |
| 2024 | 8 | 8 |
| 2025 | 4 | 18 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Extraction process of pancrelipase and evaluation thereof18 Aug 2026US 12,710,424 B2Kashiv Biosciences, LLC
- Method for the determination of hydrolytic activity11 Aug 2026US 12,704,518 B2Hoffmann-La Roche Inc.
- Biosensor and related wound dressing system17 Feb 2026US 12,551,146 B2Mölnlycke Health Care AB
- Kit for detecting soluble growth stimulation expressed gene 2 protein20 Jan 2026US 12,529,703 B2Beijing Strong Biotechnologies, Inc.
- Method for rapidly detecting pesticide based on thin-layer chromatography and enzyme inhibition principle13 Jan 2026US 12,523,638 B2Institute of Quality Standard and Testing Technology for Agro-Products, Caas
- Risankizumab compositions1 Oct 2026US 2026/0297178 A1AbbVie Inc.
- Glycoprotein biomarkers for ovarian cancer diagnosis1 Oct 2026US 2026/0298932 A1Proseek Bio Pty Ltd.
- Risankizumab compositions24 Sep 2026US 2026/0285967 A1AbbVie Inc.
- Extraction process of pancrelipase and evaluation thereof17 Sep 2026US 2026/0276638 A1Kashiv Biosciences, LLC
- Risankizumab compositions10 Sep 2026US 2026/0265366 A1AbbVie Inc.
Most cited
By later US patents
- Methods of producing nucleic acid ligands204US 5,595,877 ANeXstar Pharmaceuticals, Inc. · 1997
- Nucleic acid ligands to HIV-RT and HIV-1 rev178US 5,496,938 ANeXstar Pharmaceuticals, Inc. · 1996
- Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase152US 5,503,978 AUniversity Research Corporation · 1996
- Methods for identifying nucleic acid ligands of human neutrophil elastase115US 5,472,841 ANeXstar Pharmaceuticals, Inc. · 1995
- High affinity ssDNA ligands of HIV-1 reverse transcriptase113US 5,786,462 ANeXstar Pharmaceuticals, Inc. · 1998